doi:10.3969/j.issn.1673-8640.2024.03.018

Abstract

CLC Number:

R378.99

Figures/Tables 7

References 16

[1]	VERMA R, KRAVITZ G R. Corynebacterium striatum empyema and osteomyelitis in a patient with advanced rheumatoid arthritis[J]. BMJ Case Rep, 2016, 2016:bcr2016214691.
[2]	葛燕梅. 纹带棒状杆菌致机会性感染的研究进展[J]. 检验医学与临床, 2021, 18(22):3344-3348.
[3]	Clinical and Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated of fastidious bacteria[S]. M45,CLSI, 2011.
[4]	DATTA P, GUPTA V, GUPTA M, et al. Corynebacterium striatum,an emerging nosocomial pathogen:case reports[J]. Infect Disord Drug Targets, 2021, 21(2):301 -303. DOI URL
[5]	GE Y, LU J, FENG S, et al. A case of catheter related bloodstream infection by Corynebacterium striatum[J]. ID Cases, 2020, 22:e00987.
[6]	YATERA K, MUKAE H. Corynebacterium species as one of the major causative pathogens of bacterial pneumonia[J]. Respir Investig, 2020, 58(3):131-133. DOI URL
[7]	MIYAMOTO M, TSUBOI R, HARADA K, et al. Skin microbiome of patients with interdigital tinea pedis:Corynebacterium striatum is more abundant in the patients[J]. J Dermatol, 2021, 48(7):1106-1108. DOI URL
[8]	SYED M A, ASHCHERKIN N, SUNDHU M, et al. Recurrent bacteremia with Corynebacterium striatum after prosthetic valve replacement:a case report[J]. Cureus, 2019, 11(5):e4670.
[9]	DAISUKE U, OISHI T, YAMANE K, et al. Corynebacterium striatum bacteremia associated with a catheter-related blood stream infection[J]. Case Rep Infect Dis, 2017, 2017:2682149.
[10]	林天来, 黄玲, 黄秀婷, 等. 老年人下呼吸道痰液检出纹带棒状杆菌的易感因素和疗效分析[J]. 中华老年医学杂志, 2022, 41(9):1061-1065.
[11]	张炽伦, 杨晓华, 谭南, 等. 纹带棒状杆菌的临床特点和耐药表型分析[J]. 现代诊断与治疗, 2021, 32(24):3995-3996.
[12]	赵智凝, 黄黎明, 李鹏. 纹带棒状杆菌感染临床特征及耐药性分析[J]. 现代检验医学杂志, 2019, 34(5):106-108.
[13]	徐帅, 王雪冰, 周海健, 等. 纹带棒状杆菌耐药性及院内传播特征分析[J]. 临床检验杂志, 2021, 39(11):817-821.
[14]	SILVA-SANTANA G, SILVA C M F, OLIVELLA J G B, et al. Worldwide survey of Corynebacterium striatum increasingly associated with human invasive infections,nosocomial outbreak,and antimicrobial multidrug-resistance,1976-2020[J]. Arch Microbiol, 2021, 203(5):1863-1880. DOI
[15]	REDDY B S, CHAUDHURY A, KALAWAT U, et al. Isolation,speciation,and antibiogram of clinically relevant non-diphtherial corynebacteria(diphtheroids)[J]. Indian J Med Microbiol, 2012, 30(1):52-57. DOI URL
[16]	MCMULLEN A R, ANDERSON N, WALLACE M A, et al. When good bugs go bad:epidemiology and antimicrobial resistance profiles of Corynebacterium striatum,an emerging multidrug-resistant,opportunistic pathogen[J]. Antimicrob Agents Chemother, 2017, 61(11):e01111-e01117.

抗菌药物	光滑型 MIC^①	粗糙型 MIC^①	参考折点
抗菌药物	光滑型 MIC^①	粗糙型 MIC^①	敏感	中介	耐药
青霉素	≥4	≥4	≤1	2	≥4
头孢曲松	4	4	≤1	2	≥4
美罗培南	≤0.25	≤0.25	≤4	8	≥16
万古霉素	≤1	≤1	≤4
红霉素	≥8	≥8	≤0.5	1	≥2
环丙沙星	4	4	≤1	2	≥4
四环素	≤1	≤1	≤4	8	≥16
复方磺胺甲噁唑	≤0.5/9.5	≤0.5/9.5	≤2/38		≥4/76
利福平	≤0.5	≤0.5	≤1	2	≥4
利奈唑胺	≤2	≤2	≤2
喹奴普丁-达福普丁	≤1	≤1	≤1	2	≥4
氯霉素	≤0.5	≤0.5	≤0.5	1-2	≥4
庆大霉素	≤4	≤4	≤4	8	≥16

抗菌药物	光滑型 MIC^①	粗糙型 MIC^①	参考折点
抗菌药物	光滑型 MIC^①	粗糙型 MIC^①	敏感	中介	耐药
青霉素	≥4	≥4	≤1	2	≥4
头孢曲松	4	4	≤1	2	≥4
美罗培南	≤0.25	≤0.25	≤4	8	≥16
万古霉素	≤1	≤1	≤4
红霉素	≥8	≥8	≤0.5	1	≥2
环丙沙星	4	4	≤1	2	≥4
四环素	≤1	≤1	≤4	8	≥16
复方磺胺甲噁唑	≤0.5/9.5	≤0.5/9.5	≤2/38		≥4/76
利福平	≤0.5	≤0.5	≤1	2	≥4
利奈唑胺	≤2	≤2	≤2
喹奴普丁-达福普丁	≤1	≤1	≤1	2	≥4
氯霉素	≤0.5	≤0.5	≤0.5	1-2	≥4
庆大霉素	≤4	≤4	≤4	8	≥16

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 7

References 16

Related Articles 15

Recommended Articles

Metrics

[1]	YU Feng, HU Longhua, XIAO Yanping, YANG Junping. Virulence genes and molecular characteristics of Klebsiella pneumoniae isolated from bloodstream infection patients [J]. Laboratory Medicine, 2024, 39(3): 249-255.
[2]	. [J]. Laboratory Medicine, 2024, 39(3): 298-301.
[3]	WANG Yanyan, WANG Junrui, ZHENG Wenqi, LAN Haixia, GUO Sufang. Drug resistance of Bacteroides isolated from clinic and characteristics of Bacteroides fragilis bft genotyping [J]. Laboratory Medicine, 2024, 39(1): 47-52.
[4]	CHEN Qing, XU Rong, SUN Jingyong. Resistance mechanisms and molecular epidemiology of Pseudomonas aeruginosa from patients with bronchiectasis in Shanghai [J]. Laboratory Medicine, 2023, 38(11): 1020-1025.
[5]	DENG Chen, DAI Jiaze, QIU Lihong, SHEN Weiting, CAI Mufa, LUO Wenying. Molecular epidemic characteristics of hypervirulent Klebsiella pneumoniae in Zhanjiang [J]. Laboratory Medicine, 2023, 38(11): 1026-1031.
[6]	. [J]. Laboratory Medicine, 2023, 38(11): 1109-1110.
[7]	ZHU Yurong, ZHANG Dan, HE Yaxing, LI Jingjing, HUANG Jing, LI Ting, LIU Peng, LIU Ronghua. Classification and epidemiology characteristics of Klebsiella pneumoniae isolated from clinic [J]. Laboratory Medicine, 2023, 38(5): 435-440.
[8]	. [J]. Laboratory Medicine, 2022, 37(11): 1075-1078.
[9]	YAN Xisheng, LEI Lei, WANG Jian. Relationship between Helicobacter pylori virulence genotypes and early renal damage in patients with peptic ulcer [J]. Laboratory Medicine, 2022, 37(1): 16-22.
[10]	. [J]. Laboratory Medicine, 2021, 36(12): 1295-1298.
[11]	HUANG Yun, LI Congrong. Research progress on hypervirulent Klebsiella pneumonia [J]. Laboratory Medicine, 2021, 36(11): 1181-1185.
[12]	GUO Wei, HUANG Jianghua, WU Bei, CHEN Fang, HE Xiaohua. Drug resistance and virulence distribution characteristics of clinical isolates of Enterococcus in a hospital [J]. Laboratory Medicine, 2020, 35(12): 1267-1271.
[13]	HE Lihua, NI Lijun, YANG Simin, YU Xiaoyu, ZHOU Aiping, HU Liang, GUO Jian, WU Wenjuan. Clinical application of RT-PCR for Klebsiella pneumoniae producing KPC carbapenemase [J]. Laboratory Medicine, 2020, 35(10): 983-987.
[14]	ZHONG Feng, FENG Yi, ZHANG Jingjing, XU Yan, FANG Yongmei, TAO Xiubin, WU Jing. In vitro antimicrobial activity and biofilm inhibitory effect of imipenem combined with tigecycline against mucoid Pseudomonas aeruginosa [J]. Laboratory Medicine, 2020, 35(6): 519-523.
[15]	CHEN Xiangming, HE Ping, LI Tin, ZHANG Haiqing, HU Yang. In vitro antibacterial activity and mechanism of artesunate on Propionibacterium acnes [J]. Laboratory Medicine, 2020, 35(4): 318-322.